Diphenhydramine combinations with other antihistamines/antitussives are Category III -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
DIPHENHYDRAMINE COMBOS WITH ANTIHISTAMINES/ANTITUSSIVES ARE CATEGORY III, according to an amendment to the OTC cough/cold combination products tentative final monograph published in the Feb. 23 Federal Register. FDA's proposal to place diphenhydramine/antihistamine and diphenhydramine/antitussive combos in Category III (data insufficient to permit classification) marks a change from the OTC panel's Category II (not safe and effective) recommendation. Combination products in this category include diphenhydramine (HCl and citrate) with dextromethorphan and diphenhydramine with chlorpheniramine.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning